The New York Times @nytimes
People with sickle cell may finally be able to live without the damage the disease causes. Two companies are seeking FDA approval for therapies that may amount to a cure. But the decision to take the drug — should it become available — is not so simple. https://t.co/pvJgsiFIYP — PolitiTweet.org